10% Owner Chernett Jorey Boosts Stake in Neuronetics with $1.4M Open Market Purchase
Summary
10% owner Chernett Jorey significantly increased their stake in Neuronetics with over $1.4 million in open market purchases, following a previous acquisition earlier this week.
Key Events
-
Significant Insider Accumulation
Chernett Jorey, a 10% owner, acquired 1,057,400 shares of common stock through open market purchases on March 18-19, 2026.
-
Substantial Investment
The total value of these purchases amounted to $1,418,490, representing over 1.3% of Neuronetics' market capitalization.
-
Continued Confidence
This follows a previous open market purchase by Chernett Jorey on March 18th, indicating a sustained buying trend by a major investor.
-
Context of Recent Events
The purchases occur after Neuronetics reported strong Q4 results and a new CEO appointment, but also after another major investor registered a large stake for potential sale.
Analysis
This substantial open market purchase by a 10% owner signals strong conviction in Neuronetics, especially coming shortly after the company reported robust Q4 results and appointed a new CEO. The accumulation of over $1.4 million in shares, representing more than 1.3% of the company's market cap, demonstrates continued confidence from a major investor. This follows a previous purchase by Chernett Jorey on March 18th, indicating a sustained buying trend. The buying activity is particularly notable given the recent S-3 filing by another major institutional investor, Madryn Asset Management, to register its entire 30% stake for potential sale, which could create an overhang.
At the time of this filing, STIM was trading at $1.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $105M. The 52-week trading range was $0.80 to $5.16. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.